Damijan Knez

Development of an in-vivo active reversible butyrylcholinesterase inhibitor

Urban Košak, Boris Brus, Damijan Knez et al. · Scientific Reports · 2016 · 159 citations · Full text

The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in Vivo Activity

Urban Košak, Boris Brus, Damijan Knez et al. · Journal of Medicinal Chemistry · 2017 · 151 citations · Full text

Combinatorial Chemistry, Scopolamine Model, Neurochemical Biomarkers +23

Design, synthesis and biological evaluation of new phthalimide and saccharin derivatives with alicyclic amines targeting cholinesterases, beta-secretase and amyloid beta aggregation

Dawid Panek, Anna Więckowska, Tomasz Wichur et al. · European Journal of Medicinal Chemistry · 2016 · 94 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, New Phthalimide +9

LiSiCA: A Software for Ligand-Based Virtual Screening and Its Application for the Discovery of Butyrylcholinesterase Inhibitors

Samo Lešnik, Tanja Štular, Boris Brus et al. · Journal of Chemical Information and Modeling · 2015 · 93 citations

Drug Target, Bioorganic Chemistry, Hit Identification +16

Tryptophan-derived butyrylcholinesterase inhibitors as promising leads against Alzheimer's disease

Damijan Knez, Marko Jukič, Xavier Brazzolotto et al. · Chemical Communications · 2019 · 92 citations